Millennium Management
VBIO

Millennium Management’s Valion Bio VBIO Stock Holding History

Millennium Management’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18
Closed -$3.2K – 6565
2023
Q2 		$3.2K Buy
+18
New +$3.86K ﹤0.01% 5910

Other funds holding VBIO

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management's VBIO Position: Q3 2023 in Review

Millennium Management sold out of Valion Bio (VBIO) in Q3 2023, closing a stake of 18 shares — an estimated $3.2K sold.

Millennium Management first reported a position in VBIO in Q2 2023 and held it in 1 quarter. The position peaked at $3.2K in Q2 2023. 6 funds tracked by Wall St. Rank hold VBIO as of Q3 2023.

  • Millennium Management reported no remaining Valion Bio position as of Q3 2023 after selling out during the quarter.
  • Millennium Management sold 18 Valion Bio shares in Q3 2023, an estimated $3.2K.
  • Millennium Management first reported a position in Valion Bio in Q2 2023 and held it in 1 quarter.
  • Millennium Management's Valion Bio position peaked at $3.2K in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Valion Bio as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.